After making headlines with its debut at Mobile World Congress in February, the Oral-B interactive SmartSeries electric toothbrush with Bluetooth 4.0 connectivity is now on sale, Procter & Gamble has announced.
Motley Fool analysts Michael Douglass and David Williamson last week discussed what kind of positive disruption pharmacy kiosk MedAvail — which is backed by Walgreens, among other investors — will have on the market.
After a five-year contraction in employer healthcare spending growth, medical inflation in the United States is projected to rise to 6.8% in 2015, according to PricewaterhouseCoopers’ Health Research Institute.
Rite Aid and Heritage Provider Network, one of California’s largest healthcare provider networks, on Tuesday announced they have entered into an agreement to bring the Rite Aid Health Alliance program to HPN’s chronic and polychronic patients across Southern California.
America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new report released by the Pharmaceutical Research and Manufacturers of America last week.
Almost 70% of adults with Type 1 diabetes never use their blood glucose self-monitoring devices or insulin pumps to download historical data about their blood sugar levels and insulin doses — information that likely would help them manage their disease better.
The Food and Drug Administration has published a draft guidance document for prescription drug supply chain stakeholders as part of the agency’s implementation of the Drug Supply Chain Security Act, the National Association of Boards of Pharmacy has reported.
Actavis confirmed that the U.S. District Court for the District of Delaware found certain claims of U.S. Patent Nos. 6,335,031 and 6,316,023 valid and infringed by the company's rivastigmine transdermal system, a generic version of Exelon Patch from Novartis.
Novo Nordisk on Thursday announced the launch of Levemir FlexTouch (insulin detemir [rDNA origin] injection), a prefilled insulin delivery mechanism, providing a new way for diabetics to administer their insulin.
Rite Aid has increased supplies of the whooping cough booster vaccine, Tdap, at all 578 California locations after the California Department of Public Health reported that the number of whooping cough cases in the state has reached “epidemic proportions.”
Walgreens has announced that it is now offering vaccinations that provide protection against pertussis (whooping cough) at all of its more than 600 stores throughout the California, as the California Department of Public Health is urging vaccination with the state reaching epidemic levels of reported whooping cough cases.
The U.S. Global Research Program in May issued an 800-page National Climate Assessment report that does not bode well for the more than 50 million Americans with allergies and asthma — their already terrible symptoms are about to get worse.
The Council for Responsible Nutrition, a trade association serving the dietary supplement industry, testified during a Senate hearing in an effort to demonstrate the industry's commitment to combat deceptive advertising of weight-loss products.
As patients across North America continue to turn to their neighborhood pharmacy for vaccinations, state and provincial governments in the United States and Canada are widening the range of immunizations that can be administered by a pharmacist.
With the ragweed season getting longer and longer, according to government reports, allergy has become a significant driver behind trips to the eye care aisle, and represents a much broader potential patient base. In response to rising temperatures, ragweed pollen season length increased between 1995 and 2011 by as much as 11 days (to 27 days) in parts of the United States and Canada.
The need state for allergy remedies is significant, according to documents filed by Merck recently in support of its application to switch Singulair. Allergies represent the fifth most-common chronic disease in the United States, impacting 1-in-5 Americans. As many as 90% of allergy sufferers self-treat their condition, and 58% only use an OTC or herbal remedy to relieve their allergy symptoms.
A survey co-released on Wednesday by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that the healthcare providers patients rely on most to explain safety information about their prescription drugs have serious concerns about a proposed FDA rule on generic drug labeling.